Switching cholinesterase inhibitor therapy in Alzheimer's disease - donepezil to rivastigmine, is it worth it?

被引：34
|
作者：
Bullock, R [1 ]
Connolly, C [1 ]
机构：
[1] Victoria Hosp, Kingshill Res Ctr, Swindon SN1 4HZ, Wilts, England
来源：
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY | 2002年 / 17卷 / 03期
关键词：
D O I：
10.1002/gps.542
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
[No abstract available]
引用
收藏
页码：288 / 289
页数：2
相关论文
共 50 条
  • [21] Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease
    Kaasinen, V
    Någren, K
    Järvenpää, T
    Roivainen, A
    Yu, MX
    Oikonen, V
    Kurki, T
    Rinne, JO
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (06) : 615 - 620
  • [22] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
    White, CM
    Dicks, RS
    FORMULARY, 1999, 34 (06) : 493 - +
  • [23] MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy
    Shamsi, Anas
    Anwar, Saleha
    Mohammad, Taj
    Alajmi, Mohamed F.
    Hussain, Afzal
    Rehman, Md. Tabish
    Hasan, Gulam Mustafa
    Islam, Asimul
    Hassan, Md. Imtaiyaz
    BIOMOLECULES, 2020, 10 (05)
  • [24] Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease
    Giacobini, E
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S3 - S10
  • [25] Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
    Wattmo, Carina
    Wallin, Asa K.
    Minthon, Lennart
    BMC NEUROLOGY, 2012, 12
  • [26] Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
    Farrimond, Lucy E.
    Roberts, Emmert
    McShane, Rupert
    BMJ OPEN, 2012, 2 (03):
  • [27] Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease
    Cagnin, Annachiara
    Cester, Alberto
    Costa, Bruno
    Ermani, Mario
    Gabelli, Carlo
    Gambina, Giuseppe
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 457 - 463
  • [28] Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
    Han, Hyun Jeong
    Lee, Jeong Ju
    Park, Sun A.
    Park, Hyun Young
    Kim, Jeong Eun
    Shim, Young Soo
    Shim, Dong-Seok
    Kim, Eun-Joo
    Yoon, Soo Jin
    Choi, Seong Hye
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (03): : 137 - 142
  • [29] Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
    Carina Wattmo
    Åsa K Wallin
    Lennart Minthon
    BMC Neurology, 12
  • [30] Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer’s disease
    Annachiara Cagnin
    Alberto Cester
    Bruno Costa
    Mario Ermani
    Carlo Gabelli
    Giuseppe Gambina
    Neurological Sciences, 2015, 36 : 457 - 463
12345